APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Details

Daily high

$79.48

Daily low

$71.39

Price at open

52 Week High

$84.56

52 Week Low

$26.20

Market cap

5.1B

Dividend yield

0.00%

Volume

220

Avg. volume

1.1M

P/E ratio

-17.32

Apogee Therapeutics News